BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21392171)

  • 1. P50 sensory gating and smoking in the general population.
    Brinkmeyer J; Mobascher A; Musso F; Schmitz M; Wagner M; Frommann I; Gründer G; Spreckelmeyer KN; Wienker T; Díaz-Lacava A; Holler D; Dahmen N; Thuerauf N; Clepce M; Kiefer F; de Millas W; Gallinat J; Winterer G
    Addict Biol; 2011 Jul; 16(3):485-98. PubMed ID: 21392171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and late auditory sensory gating: moderating influences from schizotypal personality, tobacco smoking status, and acute smoking.
    Wan L; Crawford HJ; Boutros N
    Psychiatry Res; 2007 May; 151(1-2):11-20. PubMed ID: 17292483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism.
    Knott V; Millar A; Fisher D; Albert P
    Neuroscience; 2010 Mar; 166(1):145-56. PubMed ID: 19961902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of nicotine on P50 amplitude, its gating, and their neural sources in low and high suppressors.
    Knott VJ; Fisher DJ; Millar AM
    Neuroscience; 2010 Oct; 170(3):816-26. PubMed ID: 20643194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P50 sensory gating: impact of high vs. low schizotypal personality and smoking status.
    Wan L; Crawford HJ; Boutros N
    Int J Psychophysiol; 2006 Apr; 60(1):1-9. PubMed ID: 15955583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential sensory gating functions between smokers and non-smokers among drug-naive first episode schizophrenic patients.
    Chen XS; Li CB; Smith RC; Xiao ZP; Wang JJ
    Psychiatry Res; 2011 Aug; 188(3):327-33. PubMed ID: 21216472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating.
    Quednow BB; Brinkmeyer J; Mobascher A; Nothnagel M; Musso F; Gründer G; Savary N; Petrovsky N; Frommann I; Lennertz L; Spreckelmeyer KN; Wienker TF; Dahmen N; Thuerauf N; Clepce M; Kiefer F; Majic T; Mössner R; Maier W; Gallinat J; Diaz-Lacava A; Toliat MR; Thiele H; Nürnberg P; Wagner M; Winterer G
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6271-6. PubMed ID: 22451930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P50 sensory gating in adolescents from a pacific island isolate with elevated risk for schizophrenia.
    Myles-Worsley M; Ord L; Blailes F; Ngiralmau H; Freedman R
    Biol Psychiatry; 2004 Apr; 55(7):663-7. PubMed ID: 15038993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensory gating and source analysis of the auditory P50 in low and high suppressors.
    Knott V; Millar A; Fisher D
    Neuroimage; 2009 Feb; 44(3):992-1000. PubMed ID: 19007892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memory impairment and auditory evoked potential gating deficit in schizophrenia.
    Hsieh MH; Liu K; Liu SK; Chiu MJ; Hwu HG; Chen AC
    Psychiatry Res; 2004 Feb; 130(2):161-9. PubMed ID: 15033186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental and genetic influences on the P50 sensory gating phenotype.
    Myles-Worsley M; Coon H; Byerley W; Waldo M; Young D; Freedman R
    Biol Psychiatry; 1996 Feb; 39(4):289-95. PubMed ID: 8645776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of nicotine on respiratory sensory gating measured by respiratory-related evoked potentials.
    Chan PY; Davenport PW
    J Appl Physiol (1985); 2010 Mar; 108(3):662-9. PubMed ID: 20056851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P50 gating in deficit and nondeficit schizophrenia.
    Santos JL; Sánchez-Morla EM; Aparicio A; García-Jiménez MA; Villanueva C; Martínez-Vizcaíno V; Arango C
    Schizophr Res; 2010 Jun; 119(1-3):183-90. PubMed ID: 20153607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auditory verbal hallucinations in schizophrenia correlate with P50 gating.
    Smith DM; Grant B; Fisher DJ; Borracci G; Labelle A; Knott VJ
    Clin Neurophysiol; 2013 Jul; 124(7):1329-35. PubMed ID: 23490551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of midlatency auditory sensory gating at short and long interstimulus intervals.
    Rentzsch J; de Castro AG; Neuhaus A; Jockers-Scherübl MC; Gallinat J
    Neuropsychobiology; 2008; 58(1):11-8. PubMed ID: 18781086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic effects of cannabis on sensory gating.
    Broyd SJ; Greenwood LM; Croft RJ; Dalecki A; Todd J; Michie PT; Johnstone SJ; Solowij N
    Int J Psychophysiol; 2013 Sep; 89(3):381-9. PubMed ID: 23628289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P50 amplitude reduction: a nicotinic receptor-mediated deficit in first-degree relatives of schizophrenia patients.
    Turetsky BI; Dent G; Jaeger J; Zukin SR
    Psychopharmacology (Berl); 2012 May; 221(1):39-52. PubMed ID: 22048129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Source localization of sensory gating: a combined EEG and fMRI study in healthy volunteers.
    Bak N; Glenthoj BY; Rostrup E; Larsson HB; Oranje B
    Neuroimage; 2011 Feb; 54(4):2711-8. PubMed ID: 21109008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The follow-up study on P50 auditory sensory gating in naïve schizophrenia].
    Wang HX; Zhang MD; Wang ZC; Chen XS; Lou FY; Liang JH; Chen C
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):601-5. PubMed ID: 20450782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P50 gating at acute and post-acute phases of first-episode schizophrenia.
    Devrim-Uçok M; Keskin-Ergen HY; Uçok A
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1952-6. PubMed ID: 18929611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.